Quinolinone derivatives as inhibitors of c-fms kinase

Details for Australian Patent Application No. 2004259755 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Wall, Mark J.; Patch, Raymond Joseph; Liu, Jian; Asgari, Davoud; Chen, Jinsheng; Meegalla, Sanath; Player, Mark R.; Illig, Carl R.; Cheung, Wing

Agent Shelston IP

Pub. Number AU-A-2004259755

PCT Pub. Number WO2005/009967

Priority 60/488,811 22.07.03 US

Filing date 20 July 2004

Wipo publication date 3 February 2005

International Classifications

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/4375 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 215/22 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009967 Priority application(s): WO2005/009967

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259760-Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions

2004259750-Soluble fragments of the SARS-CoV spike glycoprotein